In addition, these organoid models represent a series of diverse subgroups of CRPCs, including AR-dependent adenocarcinoma, AR-negative adenocarcinoma, and neuroendocrine carcinoma [17]. This evidence concerns the gene AR and neuroendocrine carcinoma.